Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Non-Current Deffered Revenue (2017 - 2021)

Catheter Precision has reported Non-Current Deffered Revenue over the past 5 years, most recently at $566000.0 for Q2 2021.

  • Quarterly Non-Current Deffered Revenue fell 33.1% to $566000.0 in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $566000.0 through Jun 2021, down 33.1% year-over-year, with the annual reading at $686000.0 for FY2020, 44.32% down from the prior year.
  • Non-Current Deffered Revenue was $566000.0 for Q2 2021 at Catheter Precision, down from $617000.0 in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $1.2 million in Q4 2019 and troughed at $566000.0 in Q2 2021.
  • The 5-year median for Non-Current Deffered Revenue is $775000.0 (2017), against an average of $853153.8.
  • Year-over-year, Non-Current Deffered Revenue surged 60.63% in 2019 and then tumbled 44.32% in 2020.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $775000.0 in 2017, then dropped by 1.03% to $767000.0 in 2018, then surged by 60.63% to $1.2 million in 2019, then tumbled by 44.32% to $686000.0 in 2020, then fell by 17.49% to $566000.0 in 2021.
  • Per Business Quant, the three most recent readings for VTAK's Non-Current Deffered Revenue are $566000.0 (Q2 2021), $617000.0 (Q1 2021), and $686000.0 (Q4 2020).